28.3% body weight loss

SpaceX's $2T IPO, Karpathy Joins Anthropic & the SaaSpocaly… · May 22, 2026

Retatrutide Phase 3 trials showed 28.3% body weight loss on 12mg over 80 weeks, significantly outperforming earlier GLP-1 drugs.